In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis

Arthritis and Rheumatology

Volumn 66, Issue 3, 2014, Pages 589-598

  Lim, Ngee Han ^a   Meinjohanns, Ernst ^b   Bou Gharios, George ^a   Gompels, Luke L ^c   Nuti, Elisa ^d   Rossello, Armando ^d   Devel, Laurent ^e   Dive, Vincent ^e   Meldal, Morten ^f   Nagase, Hideaki ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CARLSBERG LABORATORY   (Denmark)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF PISA   (Italy)

^e SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE A; ILOMASTAT; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; METALLOPROTEINASE INHIBITOR; STROMELYSIN; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE IMAGING; FORSTER RESONANCE ENERGY TRANSFER; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUBSTRATE PROBE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; DIAGNOSTIC IMAGING; FLUORESCENCE RESONANCE ENERGY TRANSFER; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE INHIBITORS; MICE; SYNOVIAL MEMBRANE;

EID: 84896283879     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38295     Document Type: Article

References (40)

1. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-73.
2. Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheum 2008;4:128-35.
3. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.
4. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993;268:23824-9.
5. Liu M, Sun H, Wang X, Koike T, Mishima H, Ikeda K, et al. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis Rheum 2004;50:3112-7.
6. Wang X, Liang J, Koike T, Sun H, Ichikawa T, Kitajima S, et al. Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits. Am J Pathol 2004;165:1375-83.
7. Jungel A, Ospelt C, Lesch M, Thiel M, Sunyer T, Schorr O, et al. Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Ann Rheum Dis 2010;69:898-902.
8. Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, Werb Z, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009;60:3723-33.
9. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO. Regulation of matrix metalloproteinase activity in health and disease. FEBS J 2011;278:28-45.
10. Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 2010;1803: 3-19.
11. Troeberg L, Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta 2012;1824: 133-45.
12. Gompels LL, Lim NH, Vincent T, Paleolog EM. In vivo optical imaging in arthritis-an enlightening future? Rheumatology (Oxford) 2010;49:1436-46.
13. Edgington LE, Verdoes M, Bogyo M. Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes. Curr Opin Chem Biol 2011;15:798-805.
14. Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 2005;1:203-9.
15. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 2007;3:668-77.
16. Edgington LE, Berger AB, Blum G, Albrow VE, Paulick MG, Lineberry N, et al. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med 2009;15:967-73.
17. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999;17:375-8.
18. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 2007;115:2292-8.
19. Caglic D, Globisch A, Kindermann M, Lim NH, Jeske V, Juretschke HP, et al. Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation. Bioorg Med Chem 2011;19:1055-61.
20. Li J, Chen K, Liu H, Cheng K, Yang M, Zhang J, et al. Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-α. Bioconjug Chem 2012;23:1704-11.
21. Chen J, Tung CH, Allport JR, Chen S, Weissleder R, Huang PL. Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation 2005;111:1800-5.
22. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 2004;101:17867-72.
23. Watzke A, Kosec G, Kindermann M, Jeske V, Nestler HP, Turk V, et al. Selective activity-based probes for cysteine cathepsins. Angew Chem Int Ed Engl 2008;47:406-9.
24. Buchardt J, Schiodt CB, Krog-Jensen C, Delaisse JM, Foged NT, Meldal M. Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors. J Comb Chem 2000;2:624-38.
25. Meldal M, Holm CB, Bojesen G, Jakobsen MH, Holm A. Multiple column peptide synthesis, Part 2 (1, 2). Int J Pept Protein Res 1993;41:250-60.
26. Troeberg L, Tanaka M, Wait R, Shi YE, Brew K, Nagase H. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A). Biochemistry 2002;41: 15025-35.
27. Devel L, Rogakos V, David A, Makaritis A, Beau F, Cuniasse P, et al. Development of selective inhibitors and substrate of matrix metalloproteinase- 12. J Biol Chem 2006;281:11152-60.
28. Yu Z, Visse R, Inouye M, Nagase H, Brodsky B. Defining the requirements for collagenase cleavage in collagen type III using a bacterial collagen system. J Biol Chem 2012;287:22988-97.
29. Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, et al. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis. J Med Chem 2009;52:4757-73.
30. Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO. Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc 2008;3:612-8.
31. Matsumoto S, Kobayashi T, Katoh M, Saito S, Ikeda Y, Kobori M, et al. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am J Pathol 1998;153:109-19.
32. Ryu JH, Lee A, Chu JU, Koo H, Ko CY, Kim HS, et al. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe. Arthritis Rheum 2011;63:3824-32.
33. + CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 2008;112:3455-64.
34. Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, et al. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis Rheum 2012;64:62-6.
35. Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, et al. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther 2006;8:R31.
36. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001;107:35-44.
37. Booth G, Newham P, Barlow R, Raines S, Zheng B, Han S. Gene expression profiles at different stages of collagen-induced arthritis. Autoimmunity 2008;41:512-21.
38. Lee S, Park K, Lee SY, Ryu JH, Park JW, Ahn HJ, et al. Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo. Bioconjug Chem 2008;19: 1743-7.
39. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-39.
40. Fingleton B. MMPs as therapeutic targets-still a viable option? Semin Cell Dev Biol 2008;19:61-8. Skin Diseases